pulmonary disease – Page 27 – Communicable Diseases Research

Invasive pulmonary aspergillosis after treatment with tocilizumab in a patient with COVID-19 ARDS: a case report

COVID-19 ARDS 환자에서 토실리주맙 치료 후 침습성 폐 아스페르길루스증: 증례 보고

Case Reports

Published on 2021-04-012022-09-11
Journal: Diagnostic microbiology and infectious disease [Category] SARS, 진단, 치료법, 치료제,

[Current microbiological aspects of community respiratory infection beyond COVID-19]

[코로나19를 넘어선 지역사회 호흡기 감염의 현재 미생물학적 측면]

Review

Published on 2021-04-012022-09-11
Journal: Revista española de quimioterapia : publicación [Category] 변종, 폐렴구균 감염증,

[키워드] Antibiotics antimicrobial antimicrobial treatment Antimicrobials Bacteria Bacterial Beta-lactam beta-lactam antibiotics chronic obstructive chronic obstructive pulmonary disease colonization Community community acquired community acquired respiratory infection community-acquired pneumonia Concentration ecological English Infection intestinal intrinsic maintaining Microbiology Microbiome microbiota microorganism mutant obstructive pulmonary disease parameters pathogen Pathogens Population Prevent profile pulmonary disease Resilience resistance mechanism resistance mechanisms respiratory infection sensitivity Spanish Treatment vaccination
[DOI] 10.37201/req/049.2021 PMC 바로가기 [Article Type] Review

Mortality and high risk of major adverse events in patients with COVID-19 and history of cardiovascular disease

Observational Study

Published on 2021-04-012022-10-05
Journal: Open Heart [Category] 임상,

[키워드] 95% CI Admission adverse event age Analysis C reactive protein cardiovascular disease Characteristics chronic obstructive collected COVID-19 CRP CT scan CVD death demographic died discharged ECG electronic medical records elevated Epidemiology Factor Gender global health Health high risk history hospitalised hospitalised patient In-hospital death in-hospital mortality increased risk independent risk factor investigated Laboratory lung infiltration male Male sex medication Mortality multivariate Older age Other outcome Patient patients with COVID-19 Primary outcome prognosis of patient pulmonary disease remained risk survived university with COVID-19
[DOI] 10.1136/openhrt-2020-001526 PMC 바로가기 [Article Type] Observational Study

Thromboinflammatory Biomarkers in COVID-19: Systematic Review and Meta-analysis of 17,052 Patients

Research article

Published on 2021-04-012022-10-05
Journal: Mayo Clinic Proceedings: Innovations, Quality & Outcomes [Category] 바이오마커, 유전자 메커니즘,

[키워드] 95% CI Biomarker biomarkers of inflammation C-reactive protein C-reactive protein (CRP Cerebrovascular disease Chronic kidney disease chronic obstructive CINAHL Controlled Coronavirus disease 2019 COVID-19 COVID-19 infection COVID-19 severity COVID-19coronavirus disease 2019 criteria CRP CRPC-reactive protein D-dimer database death diabetes disease disease severity ECMOextracorporeal membrane oxygenation end-organ damage evaluate extracorporeal membrane oxygenation ferritin fibrinogen greater group heterogeneity high-sensitivity hospitalized patient hshigh-sensitivity hypertension IL-6interleukin 6 inferences interleukin 6 lactate dehydrogenase LDHlactate dehydrogenase malignancy marker mean difference men mild infection Mortality objective Odds ratio Older OROdds Ratio parameter Patient patients Prevalence proportion pulmonary disease random-effects model Result review searched severe coronavirus disease severe COVID-19 disease severe disease severity significantly higher survivor thrombosis troponin I was used Web of Science weighted mean difference WMDweighted mean difference
[DOI] 10.1016/j.mayocpiqo.2021.01.009 [Article Type] Research article

Functional status of mechanically ventilated COVID-19 survivors at ICU and hospital discharge

Research

Published on 2021-03-312022-10-30
Journal: Journal of Intensive Care [Category] COVID-19,

[키워드] ANOVA Barthel Index Care chronic obstructive Comorbidities Comorbidity Coronavirus disease 2019 COVID-19 COVID-19 illness COVID-19 patient COVID-19 sequela demographics diabetes discharge discharged equipment evaluate Follow-up functional Functional outcome hospital discharge hypertension ICU Immunosuppression IMV In-hospital independent Invasive mechanical ventilation Laboratory tests Late effects of COVID-19 infection majority Male sex mechanically ventilated Mobility number of comorbidities Older age Patient prevalent Prospective Study pulmonary disease receiving recommendation recommendations rehabilitation rehabilitation facility required Result supplemental oxygen survivor Survivors the patient treated Vascular vital sign
[DOI] 10.1186/s40560-021-00542-y PMC 바로가기 [Article Type] Research

Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19

COVID-19의 임상 형태에 대한 바이러스 게놈, 메타게놈 및 인간 전사체 특성화 및 예측

Clinical Trial

Published on 2021-03-292022-09-10
Journal: PLoS Pathogens [Category] SARS, 유전자 메커니즘, 임상, 치료기술,

[키워드] activate activating acute respiratory distress syndrome Acute respiratory failure Analysis antagonists Bacteria candidate Candidates caused Characteristics characterized clinical form collected COVID-19 COVID-19 pneumonia CXCR2 cytokine Diagnosis disease distress ENhance Factor feature female gender form fungi Genetic genomic high mortality rate Host identify IL-8 Immune cell immune cells infiltration Inflammatory response intensive care intensive care unit lower mortality metagenomic Mild Nasopharyngeal swab nasopharyngeal swabs neutrophil neutrophil infiltration outpatients overactive overexpression pandemic parasite parasites pathophysiology pathway Patient patients hospitalized Pneumonia pulmonary disease receptor respiratory respiratory distress Respiratory distress syndrome Respiratory failure respiratory symptom respiratory symptoms resulting SARS-CoV-2 Severe case severe COVID-19 Severe COVID-19 pneumonia severe pneumonia severity severity of COVID-19 shotgun syndrome T helper the disease tissue damage transcript transcriptomic transcriptomics Treatment turn upper respiratory Viral viruses was performed were used
[DOI] 10.1371/journal.ppat.1009416 PMC 바로가기 [Article Type] Clinical Trial

Diabetes and COVID-19

Review Article

Published on 2021-03-252022-10-28
Journal: Open Life Sciences [Category] COVID-19,

[키워드] ACE2 addition Affect age approach Bacteria binding affinity blood sugar Cancer cardiovascular diseases Care Cell chronic obstructive Comorbidities Complication COVID-19 COVID-19 in patient COVID-19 patient CVD Cytokine storm Degradation diabete diabetes Diabetes Mellitus Factor Frequency Gender glycosylation Healthcare system help higher risk hyperglycemia hypertension ICU immune response increase in Increased Inflammation inflammatory markers male Mortality neutrophil chemotaxis obesity Patient patients phagocytosis physician problems Protein pulmonary disease reduce risk severity of COVID-19 significant effect susceptible Treatment Ventilation viral infections virus clearance
[DOI] 10.1515/biol-2021-0034 PMC 바로가기 [Article Type] Review Article

Influence of Hypoxia on the Epithelial-Pathogen Interactions in the Lung: Implications for Respiratory Disease

폐의 상피-병원체 상호작용에 대한 저산소증의 영향: 호흡기 질환에 대한 영향

Review

Published on 2021-03-242022-09-12
Journal: Frontiers in Immunology [Category] SARS, 진단,

[키워드] Activation addition airway airway epithelium Asthma chemokines chronic inflammation chronic obstructive complex COVID-19 Defense disease dysfunction epithelial epithelial cells Evidence fibrosis highlight Host host-pathogen interaction host-pathogen interactions hypoxia hypoxia-inducible factor (HIF)-1 Immunity indicate Infection inflamed tissue Inflammatory inflammatory lung disease influence innate immune response Innate immunity Interaction lung modulating molecular mechanism mucosal normal physiological conditions novel respiratory disease oxygen pathophysiology physical Proinflammatory cytokine Protective provided pulmonary disease receptors Region respiratory Respiratory disease Respiratory pathogens response therapeutic target tissue
[DOI] 10.3389/fimmu.2021.653969 PMC 바로가기 [Article Type] Review

Management Challenges in Chronic Obstructive Pulmonary Disease in the COVID-19 Pandemic: Telehealth and Virtual Reality

Review

Published on 2021-03-182022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

MASPs at the crossroad between the complement and the coagulation cascades – the case for COVID-19

Articles

Published on 2021-03-172022-10-31
Journal: Genetics and Molecular Biology [Category] COVID-19,

[키워드] Activation antibody Arterial hypertension association Atypical binding Biomarker Blood coagulation cardiovascular disease cascades Cerebrovascular disease Chronic kidney disease chronic obstructive Coagulation coagulation cascade Comorbidity complement complement system component COVID-19 COVID-19 patient COVID-19 patients diabetes Diseases Efficiency encoded proteins functional highlight in viral increased expression Inflammation inhibitor lectin pathway mannose MASP MASP-2 MASP1 MASP2 modulating new treatment strategy parameter patients with COVID-19 positive result progression pulmonary disease reported risk serine protease severity subsequent susceptibility therapeutic target variant
[DOI] 10.1590/1678-4685-GMB-2020-0199 PMC 바로가기 [Article Type] Articles